Chronic obstructive pulmonary disease (COPD) COPD, balance, immobility, prevalence
Conditions
Interventions
Sponsors
None listed
Eligibility
Inclusion criteria
Inclusion criteria: COPD patients with 1. aged 18-70 years 2. post-bronchodilator FEV1/FVC ratio of less than 0.7 and no significant bronchodilator response based on spirometry.
Exclusion criteria
Exclusion criteria: 1. Individuals who decline to participate. 2. History of acute exacerbation of COPD within the past month, including worsening dyspnea and/or increased cough or sputum production. 3. Inability to complete required assessments: Berg Balance Scale, Timed Up and Go test, hand grip test, back strength test, MIP, MEP, or 6-minute walking test. 4. Inability to communicate or complete CAT, mMRC, or EQ-5D-5L questionnaires. 5. Presence of comorbidities that may affect balance, including: 5.1 Mental disorders 5.2 Uncontrolled hypertension (more than 180/120 mmHg) or hypotension (less than 90/60 mmHg) 5.3 Moderate to severe heart disease (more than NYHA class 3) 5.4 Neurological conditions such as dementia, stroke, neuromuscular disease, or any form of blindness 5.5 Pregnancy 5.6 Bedridden status 6. Participants who develop adverse symptoms during study assessments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To determine the prevalence of impaired balance in patients with chronic obstructive pulmonary disease (COPD). single time point (baseline) Balance impairment (primary outcome): assessed using balance tests such as Berg Balance Scale (BBS) and/or Timed Up and Go (TUG) test. | — |
Secondary
| Measure | Time frame |
|---|---|
| To investigate the association between impaired balance in patients with chronic obstructive pulmonary disease (COPD) and baseline characteristics, including age, sex, and body mass index (BMI) single time point (baseline) characteristic record form,To investigate the association between impaired balance in patients with COPD and disease severity, spirometry, CAT, mMRC, ABE GOLD, inhaled medications, and LTOT. single time point (baseline) pulmonary function by spirometry test, CAT, mMRC, ABE GOLD, review medical record form,To investigate the association between impaired balance in patients with COPD and muscle mass, fat mass, handgrip, back and respiratory muscle strength, and 6-minute walking test performance single time point (baseline) BC-730 body composition scale, skinfold calipers, grip dynamometer (D T.K.K.5401), back strength meter (D T.K.K.5402), respiratory pressure meter (RPM01), and 6-minute walk test (6-MWT) | — |
Countries
Thailand
Contacts
Department of Internal Medicine, Faculty of Medicine Vajira Hospital, Navamindradhiraj University